✦ LIBER ✦

Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections

✍ Scribed by Gita Wasan Patel; Nimish Patel; Asma Lat; Kristen Trombley; Sam Enbawe; Kelli Manor; Raymond Smith; Thomas P. Lodise Jr.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and evidence for extended infu

✍ Kaufman, S. E.; Donnell, R. W.; Hickey, W. S. 📂 Article 📅 2011 🏛 American Society of Health-System Pharmacists 🌐 English ⚖ 213 KB

Piperacillin-Tazobactam for Pseudomonas

✍ Lodise, T. P.; Lomaestro, B.; Drusano, G. L. 📂 Article 📅 2007 🏛 University of Chicago Press 🌐 English ⚖ 260 KB

Outcomes of Extended-Infusion Piperacill

✍ Lee, Grace C.; Liou, Hansheng; Yee, Russell; Quan, Clifford F.; Neldner, Katheri 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Comparison of fixed concentration and fi

✍ M. A. Pfaller; A. L. Barry; P. C. Fuchs; E. H. Gerlach; D. J. Hardy; J. C. McLau 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 547 KB

Optimal Dosing of Piperacillin-Tazobacta

✍ Aryun Kim; Christina A. Sutherland; Joseph L. Kuti; Dr. David P. Nicolau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Standard Versus Prolonged Doripenem Infu

✍ Hsaiky, L.; Murray, K. P.; Kokoska, L.; Desai, N.; Cha, R. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 392 KB